Annual Working Capital
$47.60 M
-$31.14 M-39.55%
December 31, 2022
Summary
- As of February 8, 2025, AGLE annual working capital is $47.60 million, with the most recent change of -$31.14 million (-39.55%) on December 31, 2022.
- During the last 3 years, AGLE annual working capital has fallen by -$8.54 million (-15.22%).
Performance
AGLE Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Working Capital
$161.08 M
+$153.43 M+2005.03%
September 30, 2023
Summary
- As of February 8, 2025, AGLE quarterly working capital is $161.08 million, with the most recent change of +$153.43 million (+2005.03%) on September 30, 2023.
- Over the past year, AGLE quarterly working capital has increased by +$96.54 million (+149.57%).
Performance
AGLE Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
AGLE Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -39.5% | +149.6% |
| 3 y3 years | -15.2% | +23.9% |
| 5 y5 years | -3.6% | +156.2% |
AGLE Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -39.6% | at low | at high | -95.2% |
| 5 y | 5-year | -64.3% | at low | at high | -95.2% |
| alltime | all time | -64.3% | -96.5% | at high | -99.0% |
Aeglea BioTherapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $161.08 M(+2005.0%) |
| Jun 2023 | - | $7.65 M(-75.9%) |
| Mar 2023 | - | $31.74 M(-33.3%) |
| Dec 2022 | $47.60 M(-39.6%) | $47.60 M(-26.2%) |
| Sep 2022 | - | $64.54 M(-20.1%) |
| Jun 2022 | - | $80.78 M(+43.5%) |
| Mar 2022 | - | $56.30 M(-28.5%) |
| Dec 2021 | $78.75 M(-40.9%) | $78.75 M(-18.9%) |
| Sep 2021 | - | $97.09 M(-14.7%) |
| Jun 2021 | - | $113.76 M(-4.4%) |
| Mar 2021 | - | $119.04 M(-10.7%) |
| Dec 2020 | $133.35 M(+137.5%) | $133.35 M(+2.5%) |
| Sep 2020 | - | $130.05 M(-10.9%) |
| Jun 2020 | - | $145.98 M(+293.2%) |
| Mar 2020 | - | $37.13 M(-33.9%) |
| Dec 2019 | $56.15 M | $56.15 M(-27.3%) |
| Sep 2019 | - | $77.23 M(-20.3%) |
| Jun 2019 | - | $96.92 M(-15.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $115.01 M(+73.1%) |
| Dec 2018 | $66.43 M(+34.6%) | $66.43 M(+5.7%) |
| Sep 2018 | - | $62.87 M(-13.5%) |
| Jun 2018 | - | $72.71 M(+68.8%) |
| Mar 2018 | - | $43.08 M(-12.7%) |
| Dec 2017 | $49.36 M(-21.0%) | $49.36 M(-9.7%) |
| Sep 2017 | - | $54.64 M(-11.6%) |
| Jun 2017 | - | $61.78 M(+9.6%) |
| Mar 2017 | - | $56.35 M(-9.8%) |
| Dec 2016 | $62.46 M(+74.6%) | $62.46 M(-7.9%) |
| Sep 2016 | - | $67.84 M(-7.8%) |
| Jun 2016 | - | $73.55 M(+134.3%) |
| Mar 2016 | - | $31.38 M(-12.2%) |
| Dec 2015 | $35.76 M(+2038.9%) | $35.76 M(-9.0%) |
| Sep 2015 | - | $39.31 M(-7.9%) |
| Jun 2015 | - | $42.67 M(-0.5%) |
| Mar 2015 | - | $42.91 M(+2466.2%) |
| Dec 2014 | $1.67 M(-47.5%) | $1.67 M |
| Dec 2013 | $3.19 M | - |
FAQ
- What is Aeglea BioTherapeutics annual working capital?
- What is the all time high annual working capital for Aeglea BioTherapeutics?
- What is Aeglea BioTherapeutics annual working capital year-on-year change?
- What is Aeglea BioTherapeutics quarterly working capital?
- What is the all time high quarterly working capital for Aeglea BioTherapeutics?
- What is Aeglea BioTherapeutics quarterly working capital year-on-year change?
What is Aeglea BioTherapeutics annual working capital?
The current annual working capital of AGLE is $47.60 M
What is the all time high annual working capital for Aeglea BioTherapeutics?
Aeglea BioTherapeutics all-time high annual working capital is $133.35 M
What is Aeglea BioTherapeutics annual working capital year-on-year change?
Over the past year, AGLE annual working capital has changed by -$31.14 M (-39.55%)
What is Aeglea BioTherapeutics quarterly working capital?
The current quarterly working capital of AGLE is $161.08 M
What is the all time high quarterly working capital for Aeglea BioTherapeutics?
Aeglea BioTherapeutics all-time high quarterly working capital is $161.08 M
What is Aeglea BioTherapeutics quarterly working capital year-on-year change?
Over the past year, AGLE quarterly working capital has changed by +$96.54 M (+149.57%)